Tamtam Try Tamtam free
Universitätsklinikum Hamburg Eppendorf logo

Universitätsklinikum Hamburg Eppendorf account plan

Healthcare and research innovations

At a glance

UKE is Hamburg's largest hospital and university medical centre, owned by the City of Hamburg, with group revenue of 1,752,999 TEUR in FY2025.

Universitätsklinikum Hamburg-Eppendorf (UKE), founded in 1889, is Hamburg's largest hospital and the maximum-care and last-resort provider for the Hamburg metropolitan region. It is a public-law corporation 100% owned by the Free and Hanseatic City of Hamburg (FHH) and combines patient care with research and teaching as the Medical Faculty of Universität Hamburg. In 2025 the UKE group treated about 595,000 patients across 14 centres with about 80 clinics and institutes, and 13 subsidiaries. FY2025 group revenue was 1,752,999 TEUR with a group annual result of -23,200 TEUR, and the group had 15,678 employees (single entity: 12,291).

Business units

Strategic priorities

Return to a balanced result
A medium-term plan agreed with the authorities targets a balanced result again in 2030, after losses of -51,350 TEUR in 2024 and -27,634 TEUR in 2025 (single entity).
Zukunftsplan 2050 campus build-out
The long-term building plan covers the University Heart and Vascular Center, the HCTI/Campus Forschung II research building, N25 and the new Martini-Klinik, financed through a tenant-landlord model (MVM).
Digital strategy (Digitale Exzellenz)
nextKAS replaces the Soarian clinical system with Navis by end-2026, nextERP replaces SAP ERP by end-2027, and nextWIS (research IT and AI) is still unfunded. At end-2024 UKE requested EUR 40.7m from the FHH for these IT needs.
Clinical AI built in-house
Through IDM gGmbH, UKE runs the ambient documentation tool ORPHEUS (in use since early 2025) and the discharge-letter model ARGO, with diagnostics support, individualised therapy and administrative relief as next products.
Research growth
Expand third-party funded research, with new DFG Collaborative Research Centres, Horizon Europe and ERC grants, and the NUM research infrastructures renewed for 2025-2030.

Latest results

In FY2025, UKE KdöR revenue rose to 1,631,607 TEUR from 1,533,639 TEUR, and the annual result improved to -27,634 TEUR from -51,350 TEUR, but equity stayed at 0. Growth came from higher activity, a higher state base rate, third-party funding and higher city allocations, set against personnel expense of 876,446 TEUR and materials of 530,379 TEUR. At group level, FY2025 revenue was 1,752,999 TEUR (2024: 1,641,774) and the annual result -23,200 TEUR (2024: -46,445), with group equity down to 0. The 2030 balanced-result target is described as much harder to reach, and unreachable if the proposed GKV reform imposes large savings on hospitals.

Investments and deals

Group capital expenditure
Group fixed-asset investment was 159,585 TEUR in 2025, after 174,511 TEUR in 2024; single-entity fixed-asset investment was 49,644 TEUR in 2025.
Fit-out loan for new buildings
A new EUR 90.0m loan funds the fit-out of the new University Heart and Vascular Center, Martini-Klinik and Campus Forschung II buildings.
Clinical IT replacement
Navis went live at AKK in April 2024, a new radiology PACS in June 2024 and a new cardiology information system in November 2024, with a patient and referrer portal and lab information system due in 2025.
Martini-Klinik new building
Treating patients since mid-2024: 17,000 m² gross floor area, 100 beds on four wards, and more than 2,500 prostate cancer operations a year.

Challenges and risks

Cost inflation not refinanced
Pay settlements and material costs are not reflected in hospital financing or research and teaching funding; about EUR 12m of nursing refinancing is lost from 2025.
Equity used up and tight liquidity
The 2024 loss left a deficit not covered by equity of 9,433 TEUR and cash fell to EUR 4.5m; liquidity rests on a EUR 92.0m FHH credit line, a EUR 34.9m liquidity loan, EUR 90.0m of bank lines and the group cash pool.
Insufficient investment funding
The tenant-landlord model leaves first equipment of new buildings to UKE's own or loan financing, and cybersecurity, nextERP and research IT cannot be financed from UKE's own resources.
Health insurance reform risk
If the planned GKV reform imposes large savings obligations on hospitals as proposed, the 2030 balanced-result target will no longer be achievable.

What leadership says

“Insgesamt wird KI in zehn Jahren ein fester Bestandteil unserer Infrastruktur sein”

Prof. Dr. Christian Gerloff, Medical Director and Chairman of the Executive Board · Techniker Krankenkasse interview "Zur Sache: Künstliche Intelligenz am UKE", 7 September 2026 (within ten years AI will be a fixed part of our infrastructure).

“Digitale Intelligenz wird menschliche Intelligenz und Nähe nicht ersetzen”

Prof. Dr. Christian Gerloff, Medical Director and Chairman of the Executive Board · Techniker Krankenkasse interview, 7 September 2026 (digital intelligence will not replace human intelligence and closeness).

Where a supplier can help

Clinical system and ERP migration support
Tied to the Digitale Exzellenz priority: the Soarian-to-Navis replacement by end-2026 and the SAP ERP replacement by end-2027 create demand for migration, integration and interface work.
Data integration across clinical systems
Tied to the clinical AI priority: the CEO names connecting findings, histories and lab results across systems as the next step, so data integration tooling that is proven in real clinical settings fits IDM's stated bar.
Equipment for new buildings
Tied to the Zukunftsplan 2050 and the insufficient investment funding challenge: first equipment for new buildings is not covered by the tenant-landlord model, so financing or leasing models for equipment may be relevant.
Cost and efficiency programmes
Tied to the balanced-result target and cost inflation challenge: offers that reduce material or personnel costs, or administrative workload, address the gap between rising costs and refinancing.
Cybersecurity and compliance
Tied to the investment funding challenge: cybersecurity cannot be financed from UKE's own resources and is largely funded through the Hospital Future Act (KHZG), so offers should fit public funding programmes.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Universitätsklinikum Hamburg Eppendorf?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Universitätsklinikum Hamburg Eppendorf

What does UKE do?

UKE is Hamburg's largest hospital and the maximum-care and last-resort provider for the Hamburg region. It also carries out research and teaching as the Medical Faculty of Universität Hamburg, and in 2025 the group treated about 595,000 patients.

What is UKE's revenue?

UKE group revenue was 1,752,999 TEUR in FY2025, with a group annual result of -23,200 TEUR. The single entity UKE KdöR had revenue of 1,631,607 TEUR and a result of -27,634 TEUR.

How many people work at UKE?

The UKE group had 15,678 employees in 2025; the single entity UKE KdöR had 12,291 employees, including 1,049 trainees.

Who owns and leads UKE?

UKE is 100% owned by the City of Hamburg. Prof. Dr. Christian Gerloff chairs the Executive Board as Medical Director, with Corinna Wriedt as Commercial Director, Joachim Prölß and Prof. Dr. Blanche Schwappach-Pignataro.

What is UKE's strategy?

UKE is building out its campus under the Zukunftsplan 2050, replacing its clinical and ERP systems under the Digitale Exzellenz strategy, developing clinical AI through IDM gGmbH, and aims for a balanced result in 2030.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)